应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03347 泰格医药
交易中 03-06 09:48:49
44.240
+0.720
+1.65%
最高
44.500
最低
43.220
成交量
9.17万
今开
44.500
昨收
43.520
日振幅
2.94%
总市值
380.91亿
流通市值
54.47亿
总股本
8.61亿
成交额
404.16万
换手率
0.07%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%
证券之星 · 03-05 22:17
泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%
泰格医药(03347)2026年2月股份变动月报表,股本保持稳定
公告速递 · 03-05 16:47
泰格医药(03347)2026年2月股份变动月报表,股本保持稳定
大和:升泰格医药(03347)目标价至45港元 上调收入预测
智通财经 · 03-04 10:18
大和:升泰格医药(03347)目标价至45港元 上调收入预测
CRO龙头,2.7亿内部大洗牌
药圈观察局 · 03-03 20:42
CRO龙头,2.7亿内部大洗牌
泰格医药(03347)完成出售上海观合医药全部已发行股本
智通财经 · 03-03 19:05
泰格医药(03347)完成出售上海观合医药全部已发行股本
每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%
市场透视 · 03-03 16:30
每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%
泰格医药盘中异动 下午盘股价大跌5.00%
市场透视 · 03-03 14:20
泰格医药盘中异动 下午盘股价大跌5.00%
《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测
AASTOCKS · 03-03 09:56
《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测
医药行业周报:哮喘与COPD:长效化、生物药加速突破
中信建投证券 · 03-01
医药行业周报:哮喘与COPD:长效化、生物药加速突破
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
市场透视 · 02-27
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%
老虎资讯综合 · 02-26
港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%
节后A股首个交易日 年轻人的“药理财”表现如何?
21世纪经济报道 · 02-24
节后A股首个交易日 年轻人的“药理财”表现如何?
每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%
市场透视 · 02-24
每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%
泰格医药02月24日主力净流出186.6万元 散户资金买入
市场透视 · 02-24
泰格医药02月24日主力净流出186.6万元 散户资金买入
盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?
智通财经 · 02-24
盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?
每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%
市场透视 · 02-20
每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%
泰格医药02月20日主力净流出45.8万元 散户资金买入
市场透视 · 02-20
泰格医药02月20日主力净流出45.8万元 散户资金买入
每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%
市场透视 · 02-16
每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%
泰格医药02月16日获主力加仓86.3万元
市场透视 · 02-16
泰格医药02月16日获主力加仓86.3万元
东吴证券:给予泰格医药买入评级
证券之星 · 02-15
东吴证券:给予泰格医药买入评级
加载更多
公司概况
公司名称:
泰格医药
所属市场:
SEHK
上市日期:
--
主营业务:
杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":44.24,"timestamp":1772761725273,"preClose":43.52,"halted":0,"volume":91700,"delay":0,"changeRate":0.016544117647058796,"floatShares":123124800,"shares":861000000,"eps":0.469437,"marketStatus":"交易中","change":0.72,"latestTime":"03-06 09:48:49","open":44.5,"high":44.5,"low":43.22,"amount":4041606,"amplitude":0.029412,"askPrice":44.24,"askSize":600,"bidPrice":44.12,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.780513,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1772769600000},"marketStatusCode":2,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":43.52,"dividendRate":0.007692,"openAndCloseTimeList":[[1772760600000,1772769600000],[1772773200000,1772784000000]],"volumeRatio":1.152431,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":57.31,"timestamp":1772761725000,"preClose":56.77,"halted":0,"volume":1269900,"delay":0,"premium":"-31.80"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2617523220","title":"泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617523220","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617523220?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:17","pubTimestamp":1772720236,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘,泰格医药报收于56.77元,较前一交易日上涨1.27%,最新总市值为488.8亿元。公司于近日发布《2026年第一次临时股东会决议的公告》。公告显示,杭州泰格医药科技股份有限公司于2026年3月5日召开2026年第一次临时股东会,会议采用现场与网络投票相结合方式,审议通过《关于变更公司注册地址及修订<公司章程>的议案》。A股及H股股东合计457人出席,代表有表决权股份431,255,969股,占公司有表决权股份总数的50.4309%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500039411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","LU1146622755.USD","03347","BK1141","BK1583","BK0077","BK0028","BK0174","LU1820825898.SGD","300347"],"gpt_icon":0},{"id":"1181886244","title":"泰格医药(03347)2026年2月股份变动月报表,股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1181886244","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181886244?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:47","pubTimestamp":1772700474,"startTime":"0","endTime":"0","summary":"2026年3月5日,泰格医药公布截至2026年2月28日的股份变动月报表。报告显示,公司A股与H股的法定股本均维持不变,A股法定股本为737,901,250股,每股面值人民币1元;H股法定股本为123,124,800股,每股面值人民币1元,总计人民币861,026,050元。根据公告,期内已发行A股总数为732,017,470股,另有5,883,780股A股被公司以库存股份形式持有,已发行H股总数为123,124,800股,均无新增发行或注销情况。截至2026年2月末,整体股本结构保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"gpt_icon":0},{"id":"2616304292","title":"大和:升泰格医药(03347)目标价至45港元 上调收入预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2616304292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616304292?lang=zh_cn&edition=full","pubTime":"2026-03-04 10:18","pubTimestamp":1772590731,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,大和发布研报称,上调对泰格医药的2026至2027年收入预测1%至7%,但下调同期每股盈利预测8%至12%,因调低毛利率并上调销售、行政开支及研发开支。维持“持有”评级,目标价由38港元升至45港元。泰格医药发盈喜,预期2025年收入同比增长1%至16%,至66.6亿至76.8亿元人民币(下同),在2024年跌11%后重拾增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","300347"],"gpt_icon":0},{"id":"2616326567","title":"CRO龙头,2.7亿内部大洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326567","media":"药圈观察局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326567?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:42","pubTimestamp":1772541743,"startTime":"0","endTime":"0","summary":"药圈观察局,最新观察:本文为共创内容,作者:#药圈观察局1组据悉,临床CRO龙头泰格医药其历时近五个月的内部资产重组正式落定。泰格医药以2.7亿元人民币的对价,将旗下临床实验服务公司上海观合医药的全部股权,出售给同属集团旗下的子公司方达医药。泰格医药2025全年预计实现归属净利润8.3亿元至12.3亿元,比上年同期增长105%至204%。但同时,2025年7月,泰格医药又通过日本子公司收购了日本MICRON公司56.37%的股权,以加强其海外布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030321211997a7dc66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030321211997a7dc66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","BK1583","BK1576","09939","BK1141","03347"],"gpt_icon":0},{"id":"2616349415","title":"泰格医药(03347)完成出售上海观合医药全部已发行股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349415","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616349415?lang=zh_cn&edition=full","pubTime":"2026-03-03 19:05","pubTimestamp":1772535909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,有关出售上海观合医药科技股份有限公司(目标公司)的全部已发行股本相关事宜。股份转让协议中所载的所有先决条件均已获达成,而出售事项于2026年3月3日根据股份转让协议的条款及条件完成。于完成出售事项后,目标公司及其子公司(统称“目标集团”)将仍作为本公司的子公司。目标集团的财务业绩将并入方达集团的财务报表。由于出售事项属于本集团内部交易,出售事项不会对本集团的综合财务状况表产生任何重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK0077","BK0216","159938","BK1141","BK1515","BK0174","BK1574","09939","LU1820825898.SGD","03347","BK1161","300347","LU1146622755.USD","BK1576","BK0028"],"gpt_icon":0},{"id":"2616326541","title":"每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326541?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526636,"startTime":"0","endTime":"0","summary":"泰格医药北京时间03月03日,跌5.79%,卖空量成交20.81万股,较上一交易日减少27.06%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163459a69cace2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163459a69cace2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03347","BK1583","BK1576"],"gpt_icon":0},{"id":"2616326683","title":"泰格医药盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326683?lang=zh_cn&edition=full","pubTime":"2026-03-03 14:20","pubTimestamp":1772518815,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘14时20分,泰格医药股票出现异动,股价急速下跌5.00%。截至发稿,该股报43.680港元/股,成交量96.0932万股,换手率0.78%,振幅7.00%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,25%的券商给予持有建议,25%的券商给予卖出建议。泰格医药股票所在的生物技术行业中,整体跌幅为3.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030314201597a7c9e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030314201597a7c9e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2616326592","title":"《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326592","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326592?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:56","pubTimestamp":1772502964,"startTime":"0","endTime":"0","summary":"大和研究报告指,泰格医药发盈喜,预期2025年收入按年增长1%至16%,至66.6亿至76.8亿元人民币(下同),在2024年跌11%后重拾增长。该行上调对泰格医药的2026至2027年收入预测1%至7%,但下调同期每股盈利预测8%至12%,因调低毛利率并上调销售、行政开支及研发开支。维持“持有”评级,目标价由38港元升至45港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101648a44455f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101648a44455f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347"],"gpt_icon":0},{"id":"2616826552","title":"医药行业周报:哮喘与COPD:长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点:哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提;行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势,同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978","BK1576","02359","BK1583","03347","BK1141","02269"],"gpt_icon":0},{"id":"2614889463","title":"每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614889463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614889463?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181035,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月27日,跌0.68%,卖空量成交8.77万股,较上一交易日减少70.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","03347","BK1141"],"gpt_icon":0},{"id":"1167195569","title":"港股异动 | 创新药板块走弱,百济神州跌近9%,药明生物跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167195569","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167195569?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:33","pubTimestamp":1772091221,"startTime":"0","endTime":"0","summary":"泰格医药、康龙化成跌超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7aeeed2b7873496584fe7f3c4e94617c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","03759","02269","06160"],"gpt_icon":0},{"id":"2614747108","title":"节后A股首个交易日 年轻人的“药理财”表现如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747108","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747108?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:38","pubTimestamp":1771936713,"startTime":"0","endTime":"0","summary":"2月24日,A股节后首个交易日,医药商业板块和医疗器械板块领涨,分别上涨1.28%和0.66%,化学制药上涨0.50%,拉长时间线看,创新药、CXO、高端医疗器械等板块正加速复苏。这一表现,也将创下公司上市以来归母净利润的历史新高。昔日“疫苗之王”智飞生物,自上市以来首次年报亏损。目前,智飞生物的代理产品收入占比高达90%,其代理的默沙东HPV疫苗业务缩水,是其业绩下滑的关键因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","06978","LU2125910500.SGD","BK1583","LU0708995583.HKD","06127","01877","09995","BK1141","02315","02359","LU2045819591.USD","BK1161","LU0052750758.USD","BK1576","BK1574","LU1046422090.SGD","03347","LU0320764599.SGD","09969"],"gpt_icon":0},{"id":"2614771348","title":"每日卖空追踪 | 泰格医药 02月24日卖空量成交5.84万股,卖空比例为4.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614771348?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921833,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月24日,跌3.6%,卖空量成交5.84万股,较上一交易日增加42.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a4c2370f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a4c2370f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1576","BK1583","BK1141"],"gpt_icon":0},{"id":"2614715847","title":"泰格医药02月24日主力净流出186.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614715847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614715847?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920952,"startTime":"0","endTime":"0","summary":"02月24日, 泰格医药股价跌3.60%,报收47.62元,成交金额6030.9万元,换手率1.03%,振幅4.13%,量比0.98。泰格医药今日主力资金净流出186.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌10.82%,主力资金累计净流入1320.8万元;近20日主力资金累计净流入4444.9万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162054a7190cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224162054a7190cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03347","BK1583","BK1576"],"gpt_icon":0},{"id":"2614771395","title":"盈利上行但现金流告急,CRO新秀博纳西亚能否“后来居上”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614771395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614771395?lang=zh_cn&edition=full","pubTime":"2026-02-24 14:59","pubTimestamp":1771916373,"startTime":"0","endTime":"0","summary":"2025年业绩回暖 毛利率稳步上行财务数据显示,博纳西亚的业绩在经历2024年的短暂回调后,于2025年重回增长轨道。据招股书披露,就2024年来自临床CRO服务的收入而言,博纳西亚在总部位于中国的市场参与者中排名第14位,市场份额为0.7%。现金流压力较大,或是公司急于上市补血的重要原因。整体来看,博纳西亚细分赛道布局清晰,走的是“小而美”的专家路线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224150431a4c1d5a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224150431a4c1d5a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","BK1583","BK1141","BK1576","BK1161","03347"],"gpt_icon":0},{"id":"2613159290","title":"每日卖空追踪 | 泰格医药 02月20日卖空量成交3.87万股,卖空比例为9.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613159290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613159290?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576233,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月20日,跌1.65%,卖空量成交3.87万股,较上一交易日减少23.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163439a4b5e92b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163439a4b5e92b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03347","BK1141","BK1583"],"gpt_icon":0},{"id":"2613160290","title":"泰格医药02月20日主力净流出45.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613160290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613160290?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575308,"startTime":"0","endTime":"0","summary":"02月20日, 泰格医药股价跌1.65%,报收48.80元,成交金额1947.3万元,换手率0.32%,振幅4.80%,量比0.15。泰格医药今日主力资金净流出45.8万元,上一交易日主力净流入404.0万元。该股近5个交易日下跌12.97%,主力资金累计净流入1784.3万元;近20日主力资金累计净流入3758.4万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161518a4b5da51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161518a4b5da51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583"],"gpt_icon":0},{"id":"2612548726","title":"每日卖空追踪 | 泰格医药 02月16日卖空量成交5.07万股,卖空比例为25.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612548726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612548726?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230630,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月16日,涨1.18%,卖空量成交5.07万股,较上一交易日减少63.42%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163426a700dfc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163426a700dfc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583"],"gpt_icon":0},{"id":"2611101717","title":"泰格医药02月16日获主力加仓86.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611101717","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611101717?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:15","pubTimestamp":1771229734,"startTime":"0","endTime":"0","summary":"02月16日, 泰格医药股价涨1.18%,报收49.62元,成交金额973.3万元,换手率0.16%,振幅4.77%,量比0.08。泰格医药今日主力资金净流入86.3万元,连续3日净流入,上一交易日主力净流入404.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.18%,平均涨幅为7.03%。该股近5个交易日下跌7.77%,主力资金累计净流入1916.3万元;近20日主力资金累计净流入3890.4万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161709a4a9ed26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161709a4a9ed26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","BK1141","03347"],"gpt_icon":0},{"id":"2611429171","title":"东吴证券:给予泰格医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2611429171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611429171?lang=zh_cn&edition=full","pubTime":"2026-02-15 09:10","pubTimestamp":1771117827,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对泰格医药进行研究并发布了研究报告《泰格医药:临床CRO龙头,扬帆启航新征程》,给予泰格医药买入评级。国内临床CRO行业经历激烈的价格竞争,供给优化,泰格医药龙头市占率持续提升,新签订单加速,有望迎来量价齐升,业绩修复增长潜力大。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为77.88。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500001037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","601555","300347"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0815},{"period":"1month","weight":-0.1687},{"period":"3month","weight":0.1275},{"period":"6month","weight":-0.1574},{"period":"1year","weight":0.2922},{"period":"ytd","weight":0.023}],"compareEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":-0.0564},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.0038},{"period":"1year","weight":0.0732},{"period":"ytd","weight":-0.0121}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03226},{"month":2,"riseRate":0.5,"avgChangeRate":0.003406},{"month":3,"riseRate":0.5,"avgChangeRate":-0.025324},{"month":4,"riseRate":0.2,"avgChangeRate":-0.055126},{"month":5,"riseRate":0.4,"avgChangeRate":0.024418},{"month":6,"riseRate":0.6,"avgChangeRate":0.024718},{"month":7,"riseRate":0.6,"avgChangeRate":0.079529},{"month":8,"riseRate":0,"avgChangeRate":-0.091864},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032065},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02594},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001375},{"month":12,"riseRate":0.5,"avgChangeRate":0.041249}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}